Membrane_NN
receptors_NNS
for_IN
aldosterone_NN
:_:
a_DT
novel_JJ
pathway_NN
for_IN
mineralocorticoid_NN
action_NN
._.

Rapid_JJ
nongenomic_JJ
in_FW
vitro_FW
effects_NNS
of_IN
aldosterone_NN
on_IN
intracellular_JJ
electrolytes_NNS
,_,
cell_NN
volume_NN
,_,
and_CC
Na_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
-_:
H_NN
+_CC
antiport_NN
have_VBP
been_VBN
found_VBN
in_IN
human_JJ
mononuclear_JJ
leukocytes_NNS
-LRB-_-LRB-
HML_NN
-RRB-_-RRB-
._.

Binding_NN
of_IN
125I-labeled_JJ
aldosterone_NN
to_TO
plasma_NN
membranes_NNS
of_IN
HML_NN
shares_VBZ
important_JJ
features_NNS
with_IN
these_DT
functional_JJ
data_NNS
._.

This_DT
includes_VBZ
a_DT
very_RB
low_JJ
apparent_JJ
dissociation_NN
constant_NN
-LRB-_-LRB-
Kd_NN
-RRB-_-RRB-
of_IN
0.1_CD
nM_NN
for_IN
both_CC
aldosterone_NN
and_CC
the_DT
effect_NN
on_IN
the_DT
Na_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
-_:
H_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
-_:
antiport_NN
,_,
a_DT
high_JJ
turnover_NN
rate_NN
,_,
and_CC
the_DT
almost_RB
exclusive_JJ
binding_NN
selectivity_NN
for_IN
aldosterone_NN
._.

Dexamethasone_NN
,_,
RU_NN
26988_CD
,_,
corticosterone_NN
,_,
ouabain_NN
,_,
amiloride_NN
,_,
and_CC
18-hydroxyprogesterone_NN
were_VBD
inactive_JJ
as_IN
ligands_NNS
._.

Deoxycorticosterone_NN
acetate_NN
had_VBD
an_DT
intermediate_JJ
activity_NN
with_IN
an_DT
apparent_JJ
Kd_NN
of_IN
100_CD
nM_NN
._.

These_DT
findings_NNS
are_VBP
the_DT
first_JJ
to_TO
demonstrate_VB
membrane_NN
binding_NN
of_IN
aldosterone_NN
being_VBG
compatible_JJ
with_IN
major_JJ
aspects_NNS
of_IN
its_PRP$
nongenomic_JJ
effects_NNS
._.

